Personalized combo therapy aims to beat head and neck cancer
Disease control
Recruiting now
This study tests which of two chemotherapy combinations works better when given with radiation for advanced head and neck cancer. About 120 participants will receive either cisplatin or a mix of docetaxel and cetuximab. Researchers will also check if a tumor marker called ERCC1 h…
Phase: PHASE2 • Sponsor: Christopher Wilke • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC